Jessica Finn
About Jessica Finn
Jessica Finn serves as the Vice President of Pathology at Ionpath, where she manages the validation of metal-conjugated antibodies for the MIBIscope™ System. She has an extensive background in pathology, having held various positions at the University of California, San Francisco, and earned her Doctor of Medicine degree from New York Medicine Jobs.
Current Role at Ionpath
Jessica Finn currently serves as the Vice President of Pathology at Ionpath, a position she has held since 2022. In this role, she manages the validation of metal-conjugated antibodies for the MIBIscope™ System, focusing on human FFPE, mouse FFPE, and mouse fresh/frozen samples. She plays a critical role in drafting and enforcing standard operating procedures to ensure data privacy compliance during quarterly security reviews. Additionally, she acts as the primary scientific point of contact for partners within the Spatial Proteomic Services division, facilitating kickoff meetings and refining statements of work.
Previous Experience at Ionpath
Before her current role, Jessica Finn worked at Ionpath as the Senior Director of Pathology from 2019 to 2021 and as the Director of Pathology from 2016 to 2019. During her tenure, she contributed to various projects and initiatives within the organization, enhancing the capabilities of the pathology department and supporting the overall mission of Ionpath.
Education and Expertise
Jessica Finn earned her Bachelor of Science in Biology from Cornell University, completing her studies from 2001 to 2005. She then pursued her Doctor of Medicine (M.D.) degree at New York Medicine Jobs, graduating in 2009. Her educational background provides a strong foundation for her expertise in pathology and medical research.
Professional Background at UCSF
Jessica Finn has extensive experience at the University of California, San Francisco (UCSF), where she held several positions. She served as a Resident in Anatomic and Clinical Pathology from 2009 to 2014, followed by her role as a Fellow in Surgical Pathology from 2012 to 2013. Additionally, she was an Assistant Professor and Medical Director of Histology and Cytology Laboratories from 2014 to 2016. Her time at UCSF contributed significantly to her professional development in the field of pathology.
Contributions to Spatial Proteomics
In her current role at Ionpath, Jessica Finn supports the quality control review process of the Spatial Proteomics Services division. She collaborates with Bioinformatics team members to ensure the delivery of high-quality results. Additionally, she is responsible for preparing written data reports and presentations that effectively communicate study results to external partners.